73 related articles for article (PubMed ID: 24069951)
21. In vivo cooperation between Bcl-xL and the phosphoinositide 3-kinase-Akt signaling pathway for the protection of epidermal keratinocytes from apoptosis.
Umeda J; Sano S; Kogawa K; Motoyama N; Yoshikawa K; Itami S; Kondoh G; Watanabe T; Takeda J
FASEB J; 2003 Apr; 17(6):610-20. PubMed ID: 12665473
[TBL] [Abstract][Full Text] [Related]
22. S100B as a potential biomarker for the detection of cytotoxicity of melanocytes.
Cheong KA; Noh M; Kim CH; Lee AY
Exp Dermatol; 2014 Mar; 23(3):165-71. PubMed ID: 24451020
[TBL] [Abstract][Full Text] [Related]
23. Melanocytes Affect Nodal Expression and Signaling in Melanoma Cells: A Lesson from Pediatric Large Congenital Melanocytic Nevi.
Margaryan NV; Gilgur A; Seftor EA; Purnell C; Arva NC; Gosain AK; Hendrix MJ; Strizzi L
Int J Mol Sci; 2016 Mar; 17(3):418. PubMed ID: 27011171
[TBL] [Abstract][Full Text] [Related]
24. Y-box Binding Protein-1 Is Part of a Complex Molecular Network Linking ΔNp63α to the PI3K/akt Pathway in Cutaneous Squamous Cell Carcinoma.
Troiano A; Lomoriello IS; di Martino O; Fusco S; Pollice A; Vivo M; La Mantia G; Calabrò V
J Cell Physiol; 2015 Sep; 230(9):2067-74. PubMed ID: 25639555
[TBL] [Abstract][Full Text] [Related]
25. Role of the pro-survival molecule Bfl-1 in melanoma.
Hind CK; Carter MJ; Harris CL; Chan HT; James S; Cragg MS
Int J Biochem Cell Biol; 2015 Feb; 59():94-102. PubMed ID: 25486183
[TBL] [Abstract][Full Text] [Related]
26. Establishment and characterization of an immortalized human giant congenital melanocytic nevi cell line.
Yu Q; Aimaier R; Chung MH; Cui X; Li Y; Wang Z; Li Q
Pigment Cell Melanoma Res; 2022 May; 35(3):356-368. PubMed ID: 35218152
[TBL] [Abstract][Full Text] [Related]
27. Bringing Down Cancer Aircraft: Searching for Essential Hypomutated Proteins in Skin Melanoma.
Pyatnitskiy M; Karpov D; Poverennaya E; Lisitsa A; Moshkovskii S
PLoS One; 2015; 10(11):e0142819. PubMed ID: 26565620
[TBL] [Abstract][Full Text] [Related]
28. Recent patents on melanoma with focus on genetic strategies.
Gramiccia T; Saraceno R; Stefani AD; Chimenti S
Recent Pat Antiinfect Drug Discov; 2008 Jun; 3(2):136-44. PubMed ID: 18673127
[TBL] [Abstract][Full Text] [Related]
29. Pluripotency markers are differentially induced by IGF1 and bFGF in cells from patients' lesions of large/giant congenital melanocytic nevi.
Basu D; Salgado CM; Patel JR; Zabec J; Hoehl RM; Bauer B; Reyes-Múgica M
Biomark Res; 2019; 7():2. PubMed ID: 30675361
[TBL] [Abstract][Full Text] [Related]
30. Canonical Signaling Pathways in Melanoma.
Sun L; Arbesman J
Clin Plast Surg; 2021 Oct; 48(4):551-560. PubMed ID: 34503716
[TBL] [Abstract][Full Text] [Related]
31. The role of Gadd45a in the survival of melanocytes and melanoma cells.
Rajpara V; Hu S; Kirsner RS
J Invest Dermatol; 2008 Jan; 128(1):4. PubMed ID: 18071330
[No Abstract] [Full Text] [Related]
32. PI3K/BCL2: illusion or promise for RS?
Frenzel LP
Blood; 2021 Jun; 137(24):3319-3321. PubMed ID: 34137851
[No Abstract] [Full Text] [Related]
33. [The function of AKT and its role in regulation of hematopoiesis and malignant hematopoiesis].
Hu T; Cheng T; Yuan W
Zhonghua Xue Ye Xue Za Zhi; 2014 Feb; 35(2):180-2. PubMed ID: 24606667
[No Abstract] [Full Text] [Related]
34. Genomic Classification of Cutaneous Melanoma.
Cancer Genome Atlas Network
Cell; 2015 Jun; 161(7):1681-96. PubMed ID: 26091043
[TBL] [Abstract][Full Text] [Related]
35. Topical therapy for regression and melanoma prevention of congenital giant nevi.
Choi YS; Erlich TH; von Franque M; Rachmin I; Flesher JL; Schiferle EB; Zhang Y; Pereira da Silva M; Jiang A; Dobry AS; Su M; Germana S; Lacher S; Freund O; Feder E; Cortez JL; Ryu S; Babila Propp T; Samuels YL; Zakka LR; Azin M; Burd CE; Sharpless NE; Liu XS; Meyer C; Austen WG; Bojovic B; Cetrulo CL; Mihm MC; Hoon DS; Demehri S; Hawryluk EB; Fisher DE
Cell; 2022 Jun; 185(12):2071-2085.e12. PubMed ID: 35561684
[TBL] [Abstract][Full Text] [Related]
36. CCL8 enhances sensitivity of cutaneous squamous cell carcinoma to photodynamic therapy by recruiting M1 macrophages.
Ji J; Wang P; Zhou Q; Zhu L; Zhang H; Zhang Y; Zheng Z; Bhatta AK; Zhang G; Wang X
Photodiagnosis Photodyn Ther; 2019 Jun; 26():235-243. PubMed ID: 30902794
[TBL] [Abstract][Full Text] [Related]
37. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response.
Jiang P; Gu S; Pan D; Fu J; Sahu A; Hu X; Li Z; Traugh N; Bu X; Li B; Liu J; Freeman GJ; Brown MA; Wucherpfennig KW; Liu XS
Nat Med; 2018 Oct; 24(10):1550-1558. PubMed ID: 30127393
[TBL] [Abstract][Full Text] [Related]
38. Sensory TRP channels contribute differentially to skin inflammation and persistent itch.
Feng J; Yang P; Mack MR; Dryn D; Luo J; Gong X; Liu S; Oetjen LK; Zholos AV; Mei Z; Yin S; Kim BS; Hu H
Nat Commun; 2017 Oct; 8(1):980. PubMed ID: 29081531
[TBL] [Abstract][Full Text] [Related]
39. MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children.
Kinsler VA; O'Hare P; Jacques T; Hargrave D; Slater O
Br J Cancer; 2017 Apr; 116(8):990-993. PubMed ID: 28253523
[TBL] [Abstract][Full Text] [Related]
40. Mutation-specific RAS oncogenicity explains NRAS codon 61 selection in melanoma.
Burd CE; Liu W; Huynh MV; Waqas MA; Gillahan JE; Clark KS; Fu K; Martin BL; Jeck WR; Souroullas GP; Darr DB; Zedek DC; Miley MJ; Baguley BC; Campbell SL; Sharpless NE
Cancer Discov; 2014 Dec; 4(12):1418-29. PubMed ID: 25252692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
